Antoman, Cristin A.

HRN: 24-69-84  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2024
AMPICILLIN 1GM (VIAL)
03/19/2024
03/21/2024
IV
2gms
Q6hrs
Leaking BOW
Waiting Final Action 
03/19/2024
CEFTRIAXONE 1G (VIAL)
03/19/2024
03/20/2024
IV
2gms
Now
For STAT CS
Waiting Final Action 
03/20/2024
CEFTRIAXONE 1G (VIAL)
03/20/2024
03/27/2024
IV
2gms
OD X 7 Days
S/P Primary CS
Waiting Final Action 
03/20/2024
METRONIDAZOLE 500MG (TAB)
03/20/2024
03/27/2024
IV
500mg
Q8hrs X 7 Days
S/P Primary CS
Waiting Final Action 
03/21/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/21/2024
03/27/2024
IV
3.75g
Q6
PCAP
Checking Final Appropriateness 
03/25/2024
METRONIDAZOLE 500MG (TAB)
03/25/2024
03/28/2024
PO
500 Mg
TID
Cystic Mass On The Vaginal Wall
Waiting Final Action 
03/28/2024
CEFUROXIME 500MG (TAB)
03/28/2024
04/04/2024
PO
500mg
BID X 7 Days
S/P Primary CS
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: